BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RTN-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RTN-001\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07142356-579@assetmemo.bio
DTSTAMP:20261121T004050Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:RTN-001: Phase 2 readout est. (NCT07142356)
DESCRIPTION:RTN-001\, phase 2\, Hypertension.\nStudy: A Study of Modified R
 elease RTN-001 In Patients With Uncontrolled Hypertension\nEstimated prima
 ry completion: March 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/rtn-001#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07142356
URL:https://assetmemo.bio/drug/rtn-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
